<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02338947</url>
  </required_header>
  <id_info>
    <org_study_id>USaoPauloGH1000</org_study_id>
    <secondary_id>Sao Paulo Research Foundation</secondary_id>
    <nct_id>NCT02338947</nct_id>
  </id_info>
  <brief_title>Off-pump Versus On-pump Coronary Artery Bypass Grafting in Frail Patients</brief_title>
  <acronym>FRAGILE</acronym>
  <official_title>A Multicenter, Prospective, Randomized, Clinical Trial Comparing Off-pump Versus On-pump Coronary Artery Bypass Grafting in Frail Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Alberto Urquiza Wanderley</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital das Clínicas Samuel Libânio</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Samaritano Paulista</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beneficência Portuguesa de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Samaritano Campinas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto Nacional de Cardiologia de Laranjeiras</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pronto-Socorro Cardiológico Universitário de Pernambuco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mount Sinai Hospital, New York</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Frailty is defined as a geriatric syndrome of impaired resiliency to stressors (such as
      cardiac surgery) that has been delineated recently in the cardiovascular literature. One of
      the most controversial areas of cardiac surgery has been whether off-pump coronary artery
      bypass grafting (OPCAB) surgery is superior to conventional on-pump coronary artery bypass
      grafting (CABG) surgery. There is an ongoing debate about the benefits and disadvantages of
      OPCAB surgery and we believe that this remains an important technique for the improvement of
      coronary surgery. The benefits of CABG surgery in frail patients are still undetermined. The
      aim of this study is to clarify the potential benefit of OPCAB surgery in pre-frail and frail
      patients by comparing off-pump versus on-pump CABG in these patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The FRAGILE protocol is a national multicenter randomized controlled trial (RCT), conducted
      in 8 Brazilian institutions. The study is already approved by a certified ethics committee.
      Funding is provided by a grant from São Paulo Research Foundation (FAPESP), which otherwise
      will not have any role in the conduct of the study nor in the analysis nor in the reporting
      of data. A confidentiality agreement regarding data use and the data safety will be monitored
      by an independent monitoring board. All the authors will provide revisions and comments and
      be testifying for the accuracy and completeness of the report, as well as for the fidelity of
      the report to the study protocol.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Eligible patients will be randomly assigned to off-pump CABG or on-pump CABG procedure.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Treatment assignments will be performed in a blinded manner according to a blocked randomization scheme with a block size of ten, stratified according to the participating center.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Major adverse cardiac and cerebrovascular events after OPCAB and CABG in pre-frail and frail patients</measure>
    <time_frame>30 days, 6 months, 1 and 2 years</time_frame>
    <description>This composite outcome comprises: all cause death, acute myocardial infarction, stroke, renal failure, acute respiratory distress syndrome and bleeding reoperation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>30 days</time_frame>
    <description>Operative time in minutes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mechanical ventilation time</measure>
    <time_frame>30 days</time_frame>
    <description>Mechanical ventilation time in hours.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hyperdynamic shock</measure>
    <time_frame>30 days</time_frame>
    <description>A cluster of symptoms that signals the onset of septic shock, often including a shaking chill, rapid rise in temperature, flushing of the skin, galloping pulse, and alternating rise and fall of the blood pressure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New onset of atrial fibrillation</measure>
    <time_frame>30 days</time_frame>
    <description>12-lead electrocardiography (ECG) to confirm the diagnosis of new onset atrial fibrillation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for pacing &gt;24 hours</measure>
    <time_frame>30 days, 6 months</time_frame>
    <description>Patient who requires pacing &gt;24 hours.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal replacement therapy</measure>
    <time_frame>30 days, 6 months</time_frame>
    <description>Any type of renal replacement therapy in a patient who does not make continued use of this.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reoperation for bleeding</measure>
    <time_frame>30 days</time_frame>
    <description>Patient has to underwent a re-thoracotomy for bleeding arising from a previous surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pneumonia</measure>
    <time_frame>30 days, 6 months</time_frame>
    <description>Physician or advanced practitioner documents the diagnosis in the medical record based on laboratory findings (e.g. positive sputum culture results from transtracheal fluid and/or bronchial washings) and/or radiological evidence (e.g. chest radiograph diagnostic of pulmonary infiltrates).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in intensive care unit</measure>
    <time_frame>30 days, 6 months</time_frame>
    <description>Total time in hours in Intensive Care Unit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in hospital</measure>
    <time_frame>30 days, 6 months</time_frame>
    <description>Total time in days in hospital.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transfusion requirement</measure>
    <time_frame>30 days</time_frame>
    <description>Number of units of blood transfused.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Graft patency</measure>
    <time_frame>6 months</time_frame>
    <description>Patency of grafts and coronary artery disease at 6 months of follow-up evaluated by angiotomography.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical and angiographic scores correlation with prognostic</measure>
    <time_frame>1 year</time_frame>
    <description>To evaluate the clinical correlation between the revascularization strategy and the usefulness of the SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery score (SYNTAX score); age, creatinine and ejection fraction score (ACEF score); clinical SYNTAX score; European System for Cardiac Operative Risk Evaluation (EuroSCORE II); The Society of Thoracic Surgeon´s risk model (STS score) and Índice de Predição do INStituto do CORação (InsCor) for prognostic evaluation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence of angina</measure>
    <time_frame>30 days, 6 months, 1 and 2 years</time_frame>
    <description>To analyse patient recurrence of angina according to the Canadian Cardiovascular Society (CCS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of complete revascularization</measure>
    <time_frame>30 days</time_frame>
    <description>To evaluate and compare the rate of complete revascularization in each one of both strategies.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Neurobehavioral outcomes after cardiac surgery</measure>
    <time_frame>6 months, 1 year</time_frame>
    <description>To evaluate the global cognitive status a examination test will be performed included 30 simple questions and tasks in a number of areas (orientation in time and place, repeating and recalling list of words, arithmetic, language use and comprehension, non-verbal memory).</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of life after cardiac surgery</measure>
    <time_frame>6 months, 1 year</time_frame>
    <description>To evaluate the quality of life by the EuroQol-registration, a five domain and a visual analogue scale (VAS). The best state they can imagine is marked by 100 and the worst state marked by 0.</description>
  </other_outcome>
  <other_outcome>
    <measure>Cost</measure>
    <time_frame>2 years</time_frame>
    <description>The adjusted amount in US dollars of the total cost of coronary artery bypass surgery for all participating hospitals will be evaluated.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">630</enrollment>
  <condition>Frail Elderly</condition>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Off-pump coronary-artery bypass grafting - OPCAB</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pre-frail and frail patients will be randomly assigned to OPCAB after the evaluation of the target vessels by an internet-based, password protected database program. The surgery will be performed as described in the &quot;intervention&quot; section and the patients will be followed up for two years.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>On-pump coronary-artery bypass grafting - CABG</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pre-frail and frail patients will be randomly assigned to CABG after the evaluation of the target vessels by an internet-based, password protected database program. The surgery will be performed as described in the &quot;intervention&quot; section and the patients will be followed up for two years.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Off-pump coronary-artery bypass grafting</intervention_name>
    <description>Surgical access to the heart will be gained through a median sternotomy in all of the patients. In order to reduce the risk of bleeding and transfusions, an absorbable hemostat will be used in the sternal bone marrow. An automatic autotransfusion system will be used to recovery of red blood cells in all patients. Off-pump surgery will be performed with the use of heart stabilizers. Patients will be heparinized with 250 IU/kg intravenously to achieve activated clotting time &gt;200s. The proximal anastomosis will be performed according to our guidelines. The distal anastomosis will be constructed with the help of mechanical stabilizers and cardiac positioner. Intracoronary shunts will be used routinely.</description>
    <arm_group_label>Off-pump coronary-artery bypass grafting - OPCAB</arm_group_label>
    <other_name>OPCAB</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>On-pump coronary-artery bypass grafting</intervention_name>
    <description>Surgical access to the heart will be gained through a median sternotomy in all of the patients. On-pump surgery will be performed in normothermia, with the use of aortic cross-clamping and cold cardioplegic arrest. Patients will be heparinized with 500 IU/kg to achieve an activated clotting time &gt;480 s. Heparin will be neutralized with 1:1 protamine sulfate. The automatic autotransfusion system will be used just in massive blood loss to recovery the red blood cells. Surgical techniques will be performed according to our guidelines.</description>
    <arm_group_label>On-pump coronary-artery bypass grafting - CABG</arm_group_label>
    <other_name>CABG</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

        - Participants aged ≥65 years with the indication of myocardial revascularization with ≥2
        criteria of frailty by Fried Frailty Criteria, and suitable to undergo either Off-pump or
        On-pump CABG.

        Exclusion criteria:

        - Patients with the indication of angioplasty or another procedure in addition to CABG;
        patients who underwent an emergency operation (within 24 hours after hospital admission);
        patients who underwent previous cardiac surgery, even with other approaches than median
        sternotomy; patients who do not have free, prior and informed consent to participate in
        this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Omar AV Mejia, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>InCor Heart Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fábio B Jatene, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>InCor Heart Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Omar AV Mejia, MD, PhD</last_name>
    <phone>55(11) 996862043</phone>
    <email>omar.mejia@incor.usp.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bianca C Meneghini, PhD</last_name>
    <phone>55(11) 26615000</phone>
    <phone_ext>5432</phone_ext>
    <email>bianca.meneghini@incor.usp.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029-6574</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital das Clínicas Samuel Libânio</name>
      <address>
        <city>Pouso Alegre</city>
        <state>Minas Gerais</state>
        <zip>37550-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandre C Hueb, MD, PhD</last_name>
      <phone>55(11) 999901932</phone>
      <email>hueb@uol.com.br</email>
    </contact>
    <investigator>
      <last_name>Natali Rodrigues, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mauricio LJ Guerrieri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexandre C Hueb, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Alberto Urquiza Wanderley</name>
      <address>
        <city>João Pessoa</city>
        <state>Paraiba</state>
        <zip>58040-300</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maurilio O Deininger, MD, PhD</last_name>
      <phone>55(83) 99816776</phone>
      <email>maurilio.od@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Eugenia G Deininger, MD, PhD</last_name>
      <phone>55(83) 91219127</phone>
      <email>eugenia.giuseppe@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Eugenia G Deininger, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maurilio O Deininger, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pronto Socorro Cardiológico de Pernambuco</name>
      <address>
        <city>Recife</city>
        <state>Pernambuco</state>
        <zip>50100-010</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michel PB de Oliveira Sá, MD, PhD</last_name>
      <phone>+55 81 9773-3190</phone>
      <email>michel_pompeu@yahoo.com.br</email>
    </contact>
    <investigator>
      <last_name>Ricardo C Lima, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michel Pompeu BO Sá, MD, MSc, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Samaritano Campinas</name>
      <address>
        <city>Campinas</city>
        <state>SP</state>
        <zip>13041-304</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gustavo AR Calado, MD, PhD</last_name>
      <phone>11999970275</phone>
      <email>gcaribeiro@yahoo.com.br</email>
    </contact>
    <investigator>
      <last_name>Mauricio M Lopes, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean MP Oliveira, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gustavo AR Calado, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Cardiologia de Laranjeiras</name>
      <address>
        <city>Rio De Janeiro</city>
        <zip>22240-002</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rodrigo C Segalote, MD, PhD</last_name>
      <phone>55 21 98275-2828</phone>
      <email>rsegalote@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Rodrigo C Segalote, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Felipe Cosentino, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Samaritano Paulista</name>
      <address>
        <city>São Paulo</city>
        <zip>01317-002</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Omar AV Mejia, MD, PhD</last_name>
      <phone>55(11) 996862043</phone>
      <email>omar.mejia@incor.usp.br</email>
    </contact>
    <investigator>
      <last_name>Pedro MB Silva, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Omar AV Mejia, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beneficência Portuguesa de São Paulo</name>
      <address>
        <city>São Paulo</city>
        <zip>01323-001</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marco AP Oliveira, MD, PhD</last_name>
      <phone>(55)11 999896032</phone>
      <email>marcoapoliveira@uol.com.br</email>
    </contact>
    <investigator>
      <last_name>Fernando F Ribas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marco AP Oliveira, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina de São Paulo</name>
      <address>
        <city>São Paulo</city>
        <zip>05403-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Omar AV Mejia, MD, PhD</last_name>
      <phone>55(11) 996862043</phone>
      <email>omar.mejia@incor.usp.br</email>
    </contact>
    <contact_backup>
      <last_name>Bianca C Meneghini, PhD</last_name>
      <phone>55(11) 999970275</phone>
      <email>bianca.meneghini@incor.usp.br</email>
    </contact_backup>
    <investigator>
      <last_name>Luís AO Dallan, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luiz AF Lisboa, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bruno M Mioto, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cibele L Garzillo, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carlos V Serrano Junior, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Filomena RG Galas, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>José C Nicolau, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luiz AM César, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Solange Andrade, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bianca C Meneghini, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roberto Kalil Filho, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fabio B Jatene, MD, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Omar AV Mejia, MD, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.fapesp.br/en</url>
    <description>São Paulo Research Foundation</description>
  </link>
  <link>
    <url>http://www.zerbini.org.br</url>
    <description>Zerbini Foundation</description>
  </link>
  <link>
    <url>http://www.sbccv.org.br</url>
    <description>Brazilian Cardiovascular Society</description>
  </link>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>August 29, 2014</study_first_submitted>
  <study_first_submitted_qc>January 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 15, 2015</study_first_posted>
  <last_update_submitted>December 5, 2019</last_update_submitted>
  <last_update_submitted_qc>December 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Frail elderly</keyword>
  <keyword>Coronary artery bypass surgery</keyword>
  <keyword>Off-pump</keyword>
  <keyword>On-pump</keyword>
  <keyword>Randomized controlled trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

